Gland Pharma Limited

rs 25

LIMITED October 11, 2022 BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers 25th floor, Dalal Street Mumbai - 400 001 Scrip Code: 543245 National Stock Exchange of India Limi

“Audio record and Transcript of the conference call will be available at www.glandpharma.com.”

Regd. Office

1

Corporate Office

1

Contact

1

Regd. Office

Survey N o . 143-148, 1 5 0 & 151, N e a r Gandimaisamma ‘X’ Roads D.P. Pally, Dundigal, Dundigal-Gandimaisamma Mandal Medchal-Malkajgiri District, Hyderabad 500043, Telangana, Tel: +91-40-30510999 Fax: +91-40-30510800 India

Corporate Office

Plot N o . 11 & 84, T S I I C Phase: I V Pashamylaram (V), Patancheru (M), Sangareddy District Hyderabad 502307, Telangana, India Tel: +91-8455-699999 CIN: L24239TG1978PLC002276 | email: gland@glandpharma.com; investors@glandpharma.com | www.glandpharma.com EARNINGS CONFERENCE CALL The Company will host Earnings conference call for second quarter of FY’23 on October 26th 2022, at 18:30 hours (IST), during which the management team will discuss the financial performance and take questions. Audio record and Transcript of the conference call will be available at www.glandpharma.com. Earnings Conference Dial-In Information Diamond pass link Universal Access National Toll Free International Toll-Free Number International Toll Number Click here to register +91 22 6280 1516 +91 22 7115 8875 1 800 120 1221 USA – 18667462133 UK – 08081011573 Singapore – 8001012045 Hong Kong – 800964448 USA + 1 3233868721 UK + 44 2034785524 Singapore + 65 31575746 Hong Kong + 852 30186877 Playback of the earning

Contact

Sumanta Bajpayee Vice President – Corporate Finance & Investor Relations E- Mail: sumanta.bajpayee@glandpharma.com and investors@glandpharma.com